|
Real-time
Euronext Paris
13:51:19 13/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.250 EUR | -2.97% |
|
-4.06% | +98.60% |
| 07-09 | THX Pharma secures its financial roadmap |  |
| 06-23 | THX Pharma appoints Sophie Jacq Lapointe to its board of directors | |
| Market Cap | 60.43M 69.75M 56.62M 51.64M 97.09M 6.65B 98.58M 666M 260M 3.33B 262M 256M 11.11B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 36.73M 42.39M 34.41M 31.39M 59.01M 4.04B 59.92M 405M 158M 2.02B 159M 156M 6.75B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.97% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.97% | ||
| 1 week | -4.06% | ||
| Current month | -1.16% | ||
| 1 month | +7.46% | ||
| 3 months | +23.19% | ||
| 6 months | +3.16% | ||
| Current year | +98.60% |
| 1 week | 4.2 |  | 4.75 |
| 1 month | 3.65 | | 4.75 |
| Current year | 1.83 | | 5.1 |
| 1 year | 1.49 | | 5.1 |
| 3 years | 0.26 | | 5.1 |
| 5 years | 0.26 | | 9.27 |
| 10 years | 0.26 | | 23.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/01/2023 | |
Christine Placet
DFI | Director of Finance/CFO | - | 01/04/2024 |
Marie Sebille
CTO | Chief Tech/Sci/R&D Officer | - | 19/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 31/03/2024 | |
| Chairman | - | 31/03/2024 | |
Julien Veys
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/3/26 A | Buy | Chief Operating Officer | 4,944 | 0.0342% | ||
| 1/28/21 A | Sell | Chief Financial Officer | 750 | 0.0207% | ||
| 1/28/21 A | Sell | Chief Financial Officer | 1,000 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.97% | -4.06% | +57.41% | +254.17% | 69.75M | |
| -0.73% | +7.82% | +73.81% | +102.34% | 70.1B | |
| +0.11% | +1.09% | +38.34% | +66.70% | 54.93B | |
| -0.22% | +33.59% | +8.43% | +489.75% | 28.89B | |
| +0.04% | +10.49% | +48.44% | +7.45% | 23.9B | |
| -0.06% | +0.61% | -16.45% | -13.26% | 23.3B | |
| -1.37% | +7.87% | +251.71% | +464.53% | 18.41B | |
| -0.37% | +8.15% | +41.22% | -19.92% | 18.77B | |
| -0.57% | +3.44% | +25.60% | +619.86% | 16.1B | |
| -1.85% | -11.15% | +32.75% | +134.11% | 12.48B | |
| Average | -0.80% | +7.09% | +56.13% | +210.57% | 26.69B | |
| Weighted average by Cap. | -0.43% | +9.42% | +54.43% | +167.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 11.9M 13.73M 11.15M 10.17M 19.12M 1.31B 19.41M 131M 51.26M 656M 51.57M 50.45M 2.19B | 4.3M 4.96M 4.03M 3.67M 6.91M 473M 7.01M 47.39M 18.52M 237M 18.63M 18.23M 790M |
| Net Debt | -23.7M -27.35M -22.21M -20.25M -38.08M -2.61B -38.66M -261M -102M -1.31B -103M -100M -4.36B | -27.4M -31.63M -25.67M -23.42M -44.02M -3.02B -44.7M -302M -118M -1.51B -119M -116M -5.04B |
Employees
12
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/08/26 | €4.250 | -2.97% | 53,749 |
| 12/08/26 | €4.380 | -2.56% | 131,833 |
| 11/08/26 | €4.495 | -1.86% | 69,203 |
| 10/08/26 | €4.580 | 0.00% | 56,939 |
| 07/08/26 | €4.580 | +3.39% | 173,537 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.380EUR
Average target price
5.800EUR
Spread / Average Target
+32.42%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHX Stock
Select your edition
All financial news and data tailored to specific country editions
